Since Kras mutation presents almost universally in PDA and is one of the earliest genetic alterations, it is reasonable to speculate that the RAS/RAF/MEK signaling plays a vital role in the non-canonical activation of Hh signaling in cancer cells. Here, KRAS is linked to cancer.